Literature DB >> 1692083

Genetically determined lack of CD45R- T cells in healthy individuals. Evidence for a regulatory polymorphism of CD45R antigen expression.

R Schwinzer1, K Wonigeit.   

Abstract

A genetic polymorphism of CD45R expression was identified resulting in a lack of CD45R- lymphocytes in approximately 8% of healthy individuals. Family studies revealed an autosomal dominant mode of inheritance of the variant CD45R expression pattern. PBMC from donors possessing the variant type did not lose the CD45R antigen after in vitro activation, whereas a decrease of CD45R molecules was readily detected in individuals with the normal pattern. The expression of CD45RO antigens, as well as memory cell function, did not differ between both groups. These data show that activation and in vivo priming of T cells is not necessarily associated with a loss of CD45R antigen expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692083      PMCID: PMC2187890          DOI: 10.1084/jem.171.5.1803

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

Review 1.  Leukocyte cell surface enzymology: CD45 (LCA, T200) is a protein tyrosine phosphatase.

Authors:  E A Clark; J A Ledbetter
Journal:  Immunol Today       Date:  1989-07

2.  Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1.

Authors:  S H Smith; M H Brown; D Rowe; R E Callard; P C Beverley
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

3.  Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.

Authors:  H M Serra; J F Krowka; J A Ledbetter; L M Pilarski
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

4.  Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression.

Authors:  J A Ledbetter; L M Rose; C E Spooner; P G Beatty; P J Martin; E A Clark
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

Review 5.  Differential expression of the leucocyte-common antigen family.

Authors:  M L Thomas; L Lefrançois
Journal:  Immunol Today       Date:  1988-10

6.  The isolation and characterization of the human suppressor inducer T cell subset.

Authors:  C Morimoto; N L Letvin; J A Distaso; W R Aldrich; S F Schlossman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

7.  Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production.

Authors:  M E Sanders; M W Makgoba; S O Sharrow; D Stephany; T A Springer; H A Young; S Shaw
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

8.  Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens.

Authors:  M Streuli; C Morimoto; M Schrieber; S F Schlossman; H Saito
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

9.  Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens.

Authors:  M Streuli; L R Hall; Y Saga; S F Schlossman; H Saito
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Different classes of T lymphocytes have different mRNAs for the leukocyte-common antigen, T200.

Authors:  L Lefrancois; M L Thomas; M J Bevan; I S Trowbridge
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation.

Authors:  L T Clement
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

2.  Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.

Authors:  C Pokoyski; T Lienen; S Rother; E Schock; A Plege-Fleck; R Geffers; R Schwinzer
Journal:  Genes Immun       Date:  2015-09-10       Impact factor: 2.676

3.  Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells.

Authors:  H S Warren; L J Skipsey
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

4.  Identical expression of CD45R isoforms by CD45RC+ 'revertant' memory and CD45RC+ naive CD4 T cells.

Authors:  M Hargreaves; E B Bell
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

Review 5.  Regulatory polymorphisms underlying complex disease traits.

Authors:  Julian C Knight
Journal:  J Mol Med (Berl)       Date:  2004-12-09       Impact factor: 4.599

6.  The levels of memory (CD45RA-, RO+) CD4+ and CD8+ peripheral blood T-lymphocytes correlate with IgM rheumatoid factors in rheumatoid arthritis.

Authors:  M Neidhart; K Fehr; F Pataki; B A Michel
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

7.  A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31.

Authors:  Bo Johanneson; Guadalupe Lima; Jenny von Salomé; Donato Alarcón-Segovia; Marta E Alarcón-Riquelme
Journal:  Am J Hum Genet       Date:  2002-10-08       Impact factor: 11.025

8.  Genetically determined CD45 variant of value in leucocyte tracing in vivo in the pig.

Authors:  R M Binns; S T Licence; A Whyte; M Wilby; H J Rothkötter; M Bacon
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

9.  Quantitative analysis of CD4+ T cell function in the course of human immunodeficiency virus infection. Gradual decline of both naive and memory alloreactive T cells.

Authors:  L Meyaard; S A Otto; B Hooibrink; F Miedema
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Differential requirements for HIV-1 replication in naive and memory CD4 T cells from asymptomatic HIV-1 seropositive carriers and AIDS patients.

Authors:  A Cayota; F Vuillier; D Scott-Algara; V Feuillie; G Dighiero
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.